0001209191-20-015191.txt : 20200303 0001209191-20-015191.hdr.sgml : 20200303 20200303163125 ACCESSION NUMBER: 0001209191-20-015191 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200227 FILED AS OF DATE: 20200303 DATE AS OF CHANGE: 20200303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bright Rex CENTRAL INDEX KEY: 0001327501 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36621 FILM NUMBER: 20682801 MAIL ADDRESS: STREET 1: 5641 LAKE VISTA DRIVE CITY: BONSALL STATE: CA ZIP: 92003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Foamix Pharmaceuticals Ltd. CENTRAL INDEX KEY: 0001606645 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 HOLZMAN ST. STREET 2: WEIZMANN SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 76704 BUSINESS PHONE: 97289316233 MAIL ADDRESS: STREET 1: 2 HOLZMAN ST. STREET 2: WEIZMANN SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 76704 FORMER COMPANY: FORMER CONFORMED NAME: Foamix Ltd. DATE OF NAME CHANGE: 20140428 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-27 0 0001606645 Foamix Pharmaceuticals Ltd. FOMX 0001327501 Bright Rex C/O FOAMIX PHARMACEUTICALS, LTD. 2 HOLZMAN STREET REHOVOT L3 7670402 ISRAEL 1 0 0 0 Options 3.53 2020-02-27 4 A 0 38156 0.00 A 2030-02-27 Ordinary Shares 38156 38156 D Each option represents a contingent right to purchase one ordinary share of the issuer. The ordinary shares underlying this option award vest over a 12 month period, in equal, quarterly installments, ending February 27, 2021. /s/ Mutya Harsch as attorney-in-fact for Rex Bright 2020-03-03